Shanghai Institute Of Biological Products
Clinical trials sponsored by Shanghai Institute Of Biological Products, explained in plain language.
-
New mpox vaccine tested on children in High-Risk region
⭐️ VACCINE ⭐️ Not yet recruitingThis study is testing a new mpox vaccine to see if it is safe and if it creates a strong immune response in the body. It will involve 180 healthy children and adults in the Democratic Republic of the Congo who have never had mpox or a related vaccine. The trial will carefully mon…
Phase: PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 14:42 UTC
-
New flu shot for seniors enters testing phase
⭐️ VACCINE ⭐️ Not yet recruitingThis study aims to test how well a new version of the flu vaccine works and how safe it is for people aged 60 and above. It will compare the new vaccine to an existing one in 1200 volunteers. The main goal is to see if the new shot triggers a strong immune response one month afte…
Phase: PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:27 UTC
-
New shot for babies aims to block dangerous RSV virus
Prevention Not yet recruitingThis study is testing a new injection called SIBP-A16 to see if it can help prevent serious illness from Respiratory Syncytial Virus (RSV) in infants. It will involve 36 premature and full-term babies under 1 year old who are entering their first RSV season. Researchers will give…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: Prevention
Last updated Apr 01, 2026 14:43 UTC